SCHEMBL2314010

SCHEMBL2314010

OCCCCc1c2ccccc2cc2cc3ccccc3cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 6/20 0.39
HSD17B10 Q99714 5/20 0.39
HPGD P15428 4/20 0.39
POLB P06746 3/20 0.39
GAA P10253 2/20 0.39
TSHR P16473 2/20 0.39
MAPT P10636 1/20 0.39
HIF1A Q16665 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2C19 P33261 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GLA P06280 1/20 0.35
GPR35 Q9HC97 2/20 0.35
CYP2C9 P11712 1/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL241214 0.93 HTR2A (0.50) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL2113583 0.91 HTR2A (0.48) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL18098077 0.91 HTR2A (0.48) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL2113231 0.91 HTR2A (0.48) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL2313164 0.87 HTR2A (0.48) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL243406 0.87 HTR2A (0.52) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL2307685 0.86 GPR84 (0.39) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL7875750 0.83 HTR2A (0.60) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL7874386 0.81 HTR2A (0.58) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10
SCHEMBL7877797 0.81 HTR2A (0.58) HTR2AL3MBTL1ALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed